Comparison of activity of different topical corticosteroid creams and ointments using a vasoconstriction assay: Superiority of hydrocortisone butyrate over hydrocortisone;Vergleich der wirksamkeit verschiedener topischer glukokortikoidcremes und -salben im vasokonstriktionstest: Überlegenheit von hydrocortisonbutyrat gegenüber hydrocortison

JDDG - Journal of the German Society of Dermatology

Volumn 3, Issue 5, 2005, Pages 348-353

  Korting, Hans Christian ^a,d   Maslen, Kirstin ^b   Groß, Gabi ^c   Willers, Christoph ^c  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b Bioskin Institute for Dermatological Research and Development GmbH   (Germany)

^c HERMAL Kurt Herrmann GmbH and Co OHG   (Germany)

^d UNIVERSITY OF MUNICH   (Germany)

Author keywords

Activity; Corticosteroids; Hydrocortisone; Hydrocortisone 17 butyrate; Mometasone furoate; Vasoconstriction assay

Indexed keywords

CORTICOSTEROID; DRUG VEHICLE; HYDROCORTISONE; HYDROCORTISONE BUTYRATE; HYDROGALEN; MOMETASONE FUROATE;

ADULT; ARTICLE; ASSAY; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREAM; DOUBLE BLIND PROCEDURE; DRUG FORMULATION; DRUG INDICATION; DRUG POTENCY; FEMALE; HUMAN; MALE; OINTMENT; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SKIN INFLAMMATION; VASOCONSTRICTION;

ADMINISTRATION, TOPICAL; ADULT; AGED; ANTI-INFLAMMATORY AGENTS; DERMATOLOGIC AGENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; OINTMENTS; PREGNADIENEDIOLS; VASOCONSTRICTION; VEHICLES;

EID: 19944409346     PISSN: 16100379     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1610-0387.2005.05719.x     Document Type: Article

References (19)

1. Gysler A, Schäfer-Korting M. Glukokortikoide. In: Korting HC, Sterry W (Hrsg): Therapeutische Verfahren in der Dermatologie. Berlin: Blackwell, 2001.
2. Niedner R. Entwicklung der topischen Kortikoide. In: Niedner R (Hrsg): Kortikoide in der Dermatologie. Bremen: Uni-Med, 1998.
3. Cornell RC, Maibach HI. Clinical Indications: Real and Assumed. In: Maibach HI, Surber C (Hrsg): Topical Corticosteroids. Basel: Karger, 1992.
4. McKenzie AW, Stoughton RB. Method for Comparing Percutaneous Absorption of Steroids. Arch Dermatol 1962; 86: 608-610.
5. Haigh JM, Kanfer I. Assessment of topical corticosteroid preparations: the human skin blanching assay. Int J Pharm 1984; 19: 245-262.
6. Guideline. Clinical investigation of corticosteroids intended for use on the skin. 1987: 347-357, Directive 75/318/EEC.
7. Bjerring P. Comparison of the Bioactivity of Mometasone Furoate 0.1% Fatty Cream, Betamethasone Dipropionate 0.05% Cream and Betamethasone Valerate 0.1% Cream in Humans. Skin Pharmacol 1993; 6: 187-192.
8. Crijns MB, Nater JP, van Oostveen F, van der Valk PGM. Vasoconstrictor and the anti-inflammatory effects of 7 corticosteroids. Contact Dermatitis 1984; 11: 108-111.
9. Ishihara M. Comparison among 6 externally applied corticosteroid agents on the vasoconstriction effect. Comparison of hydrocortisone-17-butyrate with other agents (Japanese). Yakuri to Chiryo 1975; 3: 1037-1047.
10. Queille-Roussel C, Poncet M, Schaefer H. Quantification of skin-colour changes induced by topical corticosteroid preparations using the Minolta Chroma Meter. Br J Dermatol 1991; 124: 264-270.
11. Maslen K. Clinical study Report, Bioskin, Hamburg: 1-38, Hermal, data on file.
12. Freeman S, Maibach HI. Study of irritant contact dermatitis produced by repeat patch test with sodium lauryl sulphate and assessed by visual methods, transepidermal water loss, and laser doppler velocimetry. J Am Acad Dermatol 1988; 19: 496-502.
13. Frosch PJ, Kligman AM. The chamber-scarification test for irritancy. Contact Dermatitis 1976; 2: 314-324.
14. Frosch PJ, Kligman AM. An improved procedure for assaying irritants. The scarification test. Curr Probl Dermatol 1978; 7: 69-79.
15. Frosch PJ, Kligman AM. The Duhring chamber. An improved technique for epicutaneous testing of irritant and allergic reactions. Contact Dermatitis 1979; 5: 73-81.
16. Luger T, Loske KD, Elsner P, Kapp A, Kerscher M, Korting HC, Krutmann J, Nickner R, Röcken M, Ruzicka T, Schwarz T. Topische Dermatotherapie mit Glukokortikoiden - Therapeutischer Index. JDDG 2004; 2: 629-634.
17. Kecskes A, Heger-Mahn R, Kleine-Kuhlmann R, Lange L. Comparison of the local and systemic side effects of methylprednisolone aceponate and mometasone furoate applied as ointments with equal antiinflammatory activity. J Am Acad Dermatol 1993; 29: 576-580.
18. Hoffmann K, Auer T, Stücker M, Hoffmann A, Altmeyer P. Comparison of skin atrophy and vasoconstriction due to mometasone furoate, methyl-prednisolone and hydrocortisone. J Eur Acad Dermatol Venereol 1998; 10: 137-142.
19. Kirsch J, Gibson JR, Darley CR, Burke CA. A Comparison of the Potencies of Several Diluted and Undiluted Corticosteroid Preparations Using the Vasoconstrictor Assay. Dermatologica 1983; 167: 138-141.